Adult

Atovaquone

Warning

General Information

Restricted formulary antimicrobial: For details see OUH netFormulary

Renal and hepatic impairment

Renal impairment

No dose adjustment required in renal impairment.

 

Hepatic impairment

Use with caution in patients with hepatic impairment.

Pregnancy and breastfeeding

Discuss with pharmacy.

Additional information

Atovaquone is only available on the OUHFT formulary as a liquid preparation.

References

  1. Summary of Product Characteristics (SPC) for Wellvone 750mg/ml oral suspension. Accessed via www.medicines.org.uk 26/03/18. Last updated 22/11/17
  2. The Renal Drug Database. Atovaquone. Accessed via renaldrugdatabase.com 26/03/18. Last updated 20/02/18

Editorial Information

Next review date: 02 Mar 2026